Canada Markets close in 1 hr 22 mins

Wuhan General Group (China), Inc. (WUHN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3200-0.0026 (-0.81%)
As of 1:53PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.3226
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3200 - 0.3800
52 Week Range0.0200 - 0.4300
Avg. Volume236,748
Market Cap3.029M
Beta (5Y Monthly)3.34
PE Ratio (TTM)N/A
EPS (TTM)-0.3480
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A

    Wuhan General Group Signs MOA for the Acquisition of Tsime Pharmaceuticals (PTY) Limited

    Tsime will become a subsidiary of MJ Medtech. The Tsime license grants the ability to cultivate, extract and process medicinal cannabis and sell the commodity for medicinal, scientific and any other legal purpose. The Transaction is anticipated to close within 90 days.


    Wuhan General Group Signs Collaborative Partnership LOI With Jugular for CBD Functional Foods

    Functional Food is defined as any modified food that claims to improve health or well-being by providing benefits beyond that of the traditional nutrients it contains. It is anticipated that the letter of intent will be replaced with a formal agreement governing the Partnership on or before September 30, 2020.


    Wuhan General Group Signs Manufacturing, Distribution and Sales Agreement with Cafféluxe

    Under the terms of this agreement, Cafféluxe will manufacture Wuhan's Medspresso™ CBD and Mushroom infused coffee, tea and hot chocolate beverages under GMP (Good Manufacturing Practices) certification. This enables Wuhan to have world-class quality products produced at the highest of safety standards ensuring remarkable customer experience. The agreement will facilitate the expansion of the Company's Medspresso™ brand and position the Company for local (South Africa) and international distribution.